France fines Sanofi for bad-mouthing generics

05/14/2013 | Bloomberg

France's antitrust regulator fined drugmaker Sanofi $52.8 million for casting doubt with doctors and pharmacists about the safety and efficacy of generic versions of the blood-thinner Plavix. Regulators say Sanofi urged doctors to require prescriptions for the branded drug be dispensed as written and tried to persuade pharmacists to use Sanofi's generic version instead of others.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC